Cello Health PLC using EPIC/TICKER code (LON:CLL) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘CORPORATE’ this morning by analysts at finnCap. Cello Health PLC are listed in the Consumer Services sector within AIM. finnCap have set their target price at 160 GBX on its stock. This indicates the analyst now believes there is a potential upside of 24.3% from the opening price of 128.75 GBX. Over the last 30 and 90 trading days the company share price has increased 3.25 points and decreased 7.65 points respectively. The 1 year high for the share price is 141 GBX while the 52 week low for the share price is 95 GBX.
Cello Health PLC has a 50 day moving average of 125.75 GBX and a 200 Day Moving Average share price is recorded at 120.36. There are currently 106,088,917 shares in issue with the average daily volume traded being 124,706. Market capitalisation for LON:CLL is £135,793,792 GBP.
